In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Omnicell's current price slightly undervalues its PERT-weighted fair value at $36.56 with a 7% implied upside, amid high confidence and diverse valuation methods. Financial health reveals fair liquidity and strong leverage but weak profitability and efficiency, increasing risk. Monte Carlo analysis shows high volatility and 75% downside risk scenarios below current price, indicating notable valuation uncertainty.